Acrivon Competitors and Similar CompaniesClear all
Acrivon's competitors and similar companies include Numab and OncoTherapy Science.
 Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline. |  OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics. | ||
Founding Date | Founding Date 2018 | Founding Date 2011 | Founding Date 2001 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Watertown, US HQ Lund, SE | Locations Wädenswil, CH HQ | Locations Kawasaki, JP HQ |
Employees | Employees 415% increase | Employees 681% decrease | Employees 54 |
Valuation ($) | Valuation ($) 256.1 m | Valuation ($) N/A | Valuation ($) 56.9 m |
Financial | |||
Net income | Net income ($77.9m) (FY, 2025) | Net income N/A | Net income (¥910.6m) (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
Numab
HQ
Wädenswil, CH
Employees
68↓ 1% decrease
Numab Therapeutics is an oncology-focused biopharmaceutical company.
View companyOncoTherapy Science
HQ
Kawasaki, JP
Employees
54
OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
View company